Back to timeline
COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine
O'Sullivan, J.S. et al.
Jenna Stephanie O'Sullivan
Andrew Lyne
Carl J Vaughan
2021-06-14
31
0
0
A 22-year-old woman was referred with exertional dyspnoea and chest tightness 3 weeks following a diagnosis of COVID-19. Evaluation revealed a resting sinus tachycardia and criteria for postural orthostatic tachycardia syndrome were met. After non-pharmacological interventions failed to yield symptomatic improvement, ivabradine was commenced. This intervention was followed by a substantial improvement in the patient's exercise tolerance and energy levels and an objective reduction in supine and standing heart rate.
Curator Assessments
No curator assessments yet. Sign up for updates and tell us if you'd like to be a curator.